SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings quarterly results and outlook triggered a sharp selloff, as traders focused on a wider-than-expected loss and slower 737 production ramp that pushed confidence in the turnaround and cash-flow recovery further out. Some traders called the drop an overreaction and bought the dip, while others questioned managements execution and saw more downside risk.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix shares are under pressure after weaker forward guidance and a reduced advertising outlook, with traders also citing concerns about engagement and competition from YouTube and other streaming services. The community is split between bears focused on slowing growth and persistent selling, and dip buyers who see the lower valuation as an opportunity.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports of abrupt workforce cuts in India and the Philippines, attributed to a ramp-down in a business assignment, have driven a sharp selloff. Traders are debating whether this reflects a lost major client and potential revenue pressure or routine project and staffing changes, with many seeking clarification from management and others viewing the decline as an overreaction.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

BETRs rally is drawing attention to the companys share repurchase program and recurring turnaround updates. Traders are focusing on the stocks low float and reported high short interest as a possible squeeze setup, while others caution that a squeeze is unconfirmed and trading volume may not be enough to sustain the move.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras planned Oracle Cloud Infrastructure partnership to offer its AI inference services is driving attention, with traders viewing it as a potential customer and distribution boost. Others question the deals near-term impact given its 2027 rollout and limited disclosed details, while upcoming share unlocks remain a concern.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on the delayed 80th-death trigger and final results from SELLASs Phase 3 REGAL trial of GPS in AML, with traders also watching for a possible ASH data presentation. Many bulls interpret the extended wait as a sign of longer survival and speculate about a buyout, while skeptics say the blinded trials delay does not establish efficacy and are pressing for confirmed results.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis record third-quarter results beat expectations and its raised outlook, including a stronger 2027 forecast, are driving a sharp rally. Bulls see the results as support for further gains and potential short covering, while skeptics question whether the post-earnings move will hold and cite lingering concerns about dilution, credit exposure, and the technology platform.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Attention is centered on Enphases upcoming quarterly earnings report, with traders debating whether results can beat subdued expectations and bracing for a potentially sharp post-report move. Some speculate that results leaked, but that is unconfirmed; broader concerns about weak residential solar demand, higher rates and the stocks prolonged decline add to the bearish caution, while some traders are positioning for a rebound.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Cornings quarterly earnings beat and stronger outlook, driven by demand for AI data-center fiber and optical communications, are the main focus. Traders are split between seeing the results and customer agreements as evidence of durable growth and frustration that the stock is falling despite the strong report, amid broader concerns about AI spending and capital costs.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Googles reported Willow-chip advance in magic-state cultivation and quantum error correction has revived attention across quantum stocks, with traders speculating that Infleqtions neutral-atom technology could benefit. The excitement contrasts with frustration over INFQs steep recent decline and doubts that the sector breakthrough will translate into company-specific gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Black Diamond (BDTX) Up 9.4% Since Last Earnings Report: Can It Continue?

Black Diamond (BDTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst

Black Diamond is expanding silevertinib into glioblastoma, adding long-term CNS-driven optionality while NSCLC remains the nearer-term focus.

Black Diamond Stock Outlook After Q1 Beat and Cash Runway

BDTX's Q1 beat and cash runway into 2028 keep focus on silevertinib's clinical durability, CNS profile and pivotal path.

BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know

Black Diamond's May 2026 silevertinib update showed steady NSCLC response rates, CNS activity and dose progress, but durability data remain early.

What's Going On With Black Diamond Therapeutics Stock Tuesday?

Black Diamond Therapeutics (NASDAQ: BDTX) stock climbs. Get the latest technical analysis, moving averages, and price action.read more...

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data

Black Diamond Therapeutics shares sink as phase II silevertinib data show NSCLC efficacy and CNS activity, but raise investor concerns on the early nature of the dataset.

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Black Diamond stock rises after its Q1 results reflect lower costs, a cash runway into 2028 and continued progress for lead candidate silevertinib.

Black Diamond Therapeutics (BDTX) to Release Quarterly Earnings on Monday

Black Diamond Therapeutics (NASDAQ:BDTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-black-diamond-therapeutics-inc-stock...

HC Wainwright Issues Positive Forecast for BDTX Earnings

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - HC Wainwright upped their Q1 2026 earnings estimates for shares of Black Diamond Therapeutics in a research note issued on Wednesday...

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

Investors need to pay close attention to BDTX stock based on the movements in the options market lately.

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Black Diamond Therapeutics Inc

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High

Equity

Bullish Sentiment

Shares of Black Diamond Therapeutics, Inc. (BDTX) jumped around 21% as of Wednesday noon after the company announced it had entered into a <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.blackdiamondtherapeutics.com/news-releases/news-release-details/servier-and-black-diamond-therapeutics-announce-global-licensing">licensing agreement</a> with Servier, a French pharmaceutical group.As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.Under the agreement, Black Diamond will receive an upfront payment of $70 million and can receive up to $710 million in future payments, including development and commercial sales milestone payments and tiered royalties based on net sales.The company said earlier this month that its cash, cash equivalents, and investment of $98.6 million as of the end of 2024 would be sufficient to fund operations and capital expenditure requirements into the last quarter of 2026.On Stocktwits, retail sentiment around Black Diamond’s stock rose to a year-high, jumping higher within the ‘extremely bullish’ territory (100/100). Meanwhile, message volume surged to ‘extremely high’ levels from ‘high’ in the past 24 hours.<figure class="image"><img style="aspect-ratio:810/187;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_19_140848_png_e163bd613a.webp" alt="Black Diamond Therapeutics' Sentiment Meter and Message Volume as of 2:00 p.m. ET on March 19, 2025 | Source: Stocktwits" width="810" height="187"><figcaption>Black Diamond Therapeutics' Sentiment Meter and Message Volume as of 2:00 p.m. ET on March 19, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism for the shares rising as high as $6 from its current value of over $2.&nbsp;<stembedurl>https://stocktwits.com/DaSqueeza/message/608568813</stembedurl>Another opined that a “strong reversal” is coming for the stock.<stembedurl>https://stocktwits.com/alecsalaur198/message/608560099</stembedurl><a href="https://stocktwits.com/symbol/BDTX">Black Diamond shares</a> are down by over 50% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/morgan-stanley-in-spotlight-after-reports-of-workforce-reduction/ch7kWQlRb2g">Morgan Stanley In Spotlight After Reports Of Workforce Reduction, Retail’s Yet To React</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

This Image Is A Part Of A Series On Pulmonary Pathologies. (Photo By BSIP/UIG Via Getty Images)

As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer. 

iShares Russell 2000 ETF

Vanguard Total Stock Market ETF

50bps hike

25bps hike

No change

Rate cut

The Federal Reserve announces its rate decision Wednesday, October 28 at 2:00 PM ET, followed by Chair Kevin Warsh’s press conference at 2:30 PM, after raising rates by a quarter point to 3.75%-4.00% in September, its first hike since 2023. What do you think the Fed decides on Wednesday? Vote and explain your reasoning in the comments.

Current Price	$1.69
Prev Close	$1.69
Open	$1.69
Dividend Yield	0.00%
50-Day Moving Average	$1.97
Beta	1.73
Avg. Volume	588,308.74
PE Ratio	-2.27

52-Week High	$4.94
52-Week Low	$1.60
Market Capitalization	$97.1M
EPS (Annual)	$0.3886
Price to Book	1.01
Revenue Per Employee	$3.33M

Feed

News

Sentiment

Earnings

Fundamentals

Info

BDTX Fundamentals